IBDEI02C ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,677,1,5,0)
 ;;=5^388.70
 ;;^UTILITY(U,$J,358.3,677,2)
 ;;=^37811
 ;;^UTILITY(U,$J,358.3,678,0)
 ;;=344.60^^9^86^4
 ;;^UTILITY(U,$J,358.3,678,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,678,1,4,0)
 ;;=4^Cauda Equina Synd NOS
 ;;^UTILITY(U,$J,358.3,678,1,5,0)
 ;;=5^344.60
 ;;^UTILITY(U,$J,358.3,678,2)
 ;;=^268459
 ;;^UTILITY(U,$J,358.3,679,0)
 ;;=336.0^^9^86^26
 ;;^UTILITY(U,$J,358.3,679,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,679,1,4,0)
 ;;=4^Syringomyelia
 ;;^UTILITY(U,$J,358.3,679,1,5,0)
 ;;=5^336.0
 ;;^UTILITY(U,$J,358.3,679,2)
 ;;=^116874
 ;;^UTILITY(U,$J,358.3,680,0)
 ;;=323.9^^9^86^19
 ;;^UTILITY(U,$J,358.3,680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,680,1,4,0)
 ;;=4^Myelitis,Cause Unspec
 ;;^UTILITY(U,$J,358.3,680,1,5,0)
 ;;=5^323.9
 ;;^UTILITY(U,$J,358.3,680,2)
 ;;=^334231
 ;;^UTILITY(U,$J,358.3,681,0)
 ;;=V58.81^^9^87^18
 ;;^UTILITY(U,$J,358.3,681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,681,1,4,0)
 ;;=4^Vascular Cath Intro/Adj
 ;;^UTILITY(U,$J,358.3,681,1,5,0)
 ;;=5^V58.81
 ;;^UTILITY(U,$J,358.3,681,2)
 ;;=^303461
 ;;^UTILITY(U,$J,358.3,682,0)
 ;;=995.20^^9^87^1
 ;;^UTILITY(U,$J,358.3,682,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,682,1,4,0)
 ;;=4^Adv Eff Med/Bio Subs
 ;;^UTILITY(U,$J,358.3,682,1,5,0)
 ;;=5^995.20
 ;;^UTILITY(U,$J,358.3,682,2)
 ;;=^334208
 ;;^UTILITY(U,$J,358.3,683,0)
 ;;=V70.7^^9^87^8
 ;;^UTILITY(U,$J,358.3,683,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,683,1,4,0)
 ;;=4^Exam in Clinical Trial
 ;;^UTILITY(U,$J,358.3,683,1,5,0)
 ;;=5^V70.7
 ;;^UTILITY(U,$J,358.3,683,2)
 ;;=^295597
 ;;^UTILITY(U,$J,358.3,684,0)
 ;;=V70.9^^9^87^10
 ;;^UTILITY(U,$J,358.3,684,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,684,1,4,0)
 ;;=4^General Exam NOS
 ;;^UTILITY(U,$J,358.3,684,1,5,0)
 ;;=5^V70.9
 ;;^UTILITY(U,$J,358.3,684,2)
 ;;=^295602
 ;;^UTILITY(U,$J,358.3,685,0)
 ;;=998.00^^9^87^15
 ;;^UTILITY(U,$J,358.3,685,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,685,1,4,0)
 ;;=4^Post-Op Shock NOS
 ;;^UTILITY(U,$J,358.3,685,1,5,0)
 ;;=5^998.00
 ;;^UTILITY(U,$J,358.3,685,2)
 ;;=^340612
 ;;^UTILITY(U,$J,358.3,686,0)
 ;;=998.02^^9^87^16
 ;;^UTILITY(U,$J,358.3,686,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,686,1,4,0)
 ;;=4^Post-Op Shock,Septic
 ;;^UTILITY(U,$J,358.3,686,1,5,0)
 ;;=5^998.02
 ;;^UTILITY(U,$J,358.3,686,2)
 ;;=^340581
 ;;^UTILITY(U,$J,358.3,687,0)
 ;;=958.4^^9^87^17
 ;;^UTILITY(U,$J,358.3,687,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,687,1,4,0)
 ;;=4^Traumatic Shock
 ;;^UTILITY(U,$J,358.3,687,1,5,0)
 ;;=5^958.4
 ;;^UTILITY(U,$J,358.3,687,2)
 ;;=^110195
 ;;^UTILITY(U,$J,358.3,688,0)
 ;;=995.0^^9^87^5
 ;;^UTILITY(U,$J,358.3,688,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,688,1,4,0)
 ;;=4^Anaphylactic Shock
 ;;^UTILITY(U,$J,358.3,688,1,5,0)
 ;;=5^995.0
 ;;^UTILITY(U,$J,358.3,688,2)
 ;;=^340653
 ;;^UTILITY(U,$J,358.3,689,0)
 ;;=995.29^^9^87^2
 ;;^UTILITY(U,$J,358.3,689,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,689,1,4,0)
 ;;=4^Adv Effect Unspec Drug
 ;;^UTILITY(U,$J,358.3,689,1,5,0)
 ;;=5^995.29
 ;;^UTILITY(U,$J,358.3,689,2)
 ;;=^334181
 ;;^UTILITY(U,$J,358.3,690,0)
 ;;=V65.5^^9^87^9
 ;;^UTILITY(U,$J,358.3,690,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,690,1,4,0)
 ;;=4^Feared Complaint No DX
 ;;^UTILITY(U,$J,358.3,690,1,5,0)
 ;;=5^V65.5
 ;;^UTILITY(U,$J,358.3,690,2)
 ;;=^295564
 ;;^UTILITY(U,$J,358.3,691,0)
 ;;=995.20^^9^87^3
 ;;^UTILITY(U,$J,358.3,691,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,691,1,4,0)
 ;;=4^Adv Effect Unspec Drug
 ;;^UTILITY(U,$J,358.3,691,1,5,0)
 ;;=5^995.20
 ;;^UTILITY(U,$J,358.3,691,2)
 ;;=^334208
 ;;^UTILITY(U,$J,358.3,692,0)
 ;;=780.39^^9^87^7
